C1Q inhibitor(Abzyme Therapeutics)

N/A

Report date: 2025/09/29 17:45:11

Base Information

Drug NameC1Q inhibitor(Abzyme Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionComplement C1q subcomponent inhibitors
TargetsComplement C1q subcomponent
Therapy Area/IndicationsBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbzyme Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAbzyme Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsBrain Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A